Jefferey Chen

1.2k total citations
7 papers, 575 citations indexed

About

Jefferey Chen is a scholar working on Genetics, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jefferey Chen has authored 7 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 3 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Jefferey Chen's work include Genomics and Rare Diseases (3 papers), Cancer Genomics and Diagnostics (3 papers) and BRCA gene mutations in cancer (3 papers). Jefferey Chen is often cited by papers focused on Genomics and Rare Diseases (3 papers), Cancer Genomics and Diagnostics (3 papers) and BRCA gene mutations in cancer (3 papers). Jefferey Chen collaborates with scholars based in United States, Israel and Germany. Jefferey Chen's co-authors include Hsiao‐Mei Lu, Wenbo Mu, Frank D. Böhmer, Harald App, Alexander Levitzki, Aviv Gazit, Gerald McMahon, Shuwei Li, Aaron Elliott and Mary Helen Black and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Jefferey Chen

7 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jefferey Chen United States	7	237	186	166	113	63	7	575
Linda Hogarth United Kingdom	14	56 0.2×	387 2.1×	31 0.2×	82 0.7×	48 0.8×	29	666
Ludmiła Grzybowska‐Szatkowska Poland	14	85 0.4×	215 1.2×	39 0.2×	77 0.7×	15 0.2×	42	466
Nobuaki Amino Japan	9	100 0.4×	242 1.3×	58 0.3×	25 0.2×	30 0.5×	14	457
Honghe Wang United States	15	63 0.3×	552 3.0×	24 0.1×	160 1.4×	55 0.9×	25	772
Christina Cherian United States	15	27 0.1×	465 2.5×	110 0.7×	27 0.2×	16 0.3×	24	711
Catherine Geh United Kingdom	7	24 0.1×	231 1.2×	69 0.4×	80 0.7×	59 0.9×	7	511
Kerrin Hansen Germany	8	108 0.5×	140 0.8×	49 0.3×	18 0.2×	199 3.2×	9	375
Armann Andaya United States	13	96 0.4×	330 1.8×	18 0.1×	93 0.8×	28 0.4×	20	504
Christine White Australia	10	52 0.2×	218 1.2×	18 0.1×	49 0.4×	81 1.3×	17	433
Nienke Losekoot Netherlands	11	31 0.1×	217 1.2×	38 0.2×	54 0.5×	24 0.4×	14	400

Countries citing papers authored by Jefferey Chen

Since Specialization

Citations

This map shows the geographic impact of Jefferey Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jefferey Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jefferey Chen more than expected).

Fields of papers citing papers by Jefferey Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jefferey Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jefferey Chen. The network helps show where Jefferey Chen may publish in the future.

Co-authorship network of co-authors of Jefferey Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jefferey Chen. A scholar is included among the top collaborators of Jefferey Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jefferey Chen. Jefferey Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Black, Mary Helen, Shuwei Li, Holly LaDuca, et al.. (2020). Validation of a prostate cancer polygenic risk score. The Prostate. 80(15). 1314–1321. 19 indexed citations

2.

Mu, Wenbo, Bing Li, Sitao Wu, et al.. (2018). Detection of structural variation using target captured next-generation sequencing data for genetic diagnostic testing. Genetics in Medicine. 21(7). 1603–1610. 24 indexed citations

3.

Lu, Hsiao‐Mei, Shuwei Li, Mary Helen Black, et al.. (2018). Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing. JAMA Oncology. 5(1). 51–51. 116 indexed citations

4.

Black, Mary Helen, Shuwei Li, Holly LaDuca, et al.. (2018). Polygenic risk score for breast cancer in high-risk women.. Journal of Clinical Oncology. 36(15_suppl). 1508–1508. 9 indexed citations

5.

LaDuca, Holly, Kelly D. Farwell, Huy Gia Vuong, et al.. (2017). Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. PLoS ONE. 12(2). e0170843–e0170843. 79 indexed citations

6.

Mu, Wenbo, Hsiao‐Mei Lu, Jefferey Chen, Shuwei Li, & Aaron Elliott. (2016). Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing. Journal of Molecular Diagnostics. 18(6). 923–932. 121 indexed citations

7.

Gazit, Aviv, Harald App, Gerald McMahon, et al.. (1996). Tyrphostins. 5. Potent Inhibitors of Platelet-Derived Growth Factor Receptor Tyrosine Kinase: Structure−Activity Relationships in Quinoxalines, Quinolines, and Indole Tyrphostins. Journal of Medicinal Chemistry. 39(11). 2170–2177. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact